Ledger.Open graph →
SEC Form D · filed December 31, 2024

Auron Therapeutics, Inc

Offering
$41.8M
Sold
$13.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Newton, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

D. Schuster · Newton, MAExec · DirectorDavid A. Wilson · London, United KingdomDirectorDamian A. Maggio · Garden City, NYDirectorMatthew S. Cooper · Aspen, CODirectorWilliam U. Martin · Ann Arbor, MIExec · DirectorRobert C. Wynne · Zionsville, INDirectorE. Smith · Baltimore, MDDirectorEdward Hansen · Camden, MEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗